Role of interferon as a modulator of fluoropyrimidines: Reply

被引：25

作者：

Herrmann, R

机构：

来源：

ANNALS OF ONCOLOGY | 1997年 / 8卷 / 02期

关键词：

D O I：

10.1093/oxfordjournals.annonc.a010859

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：141 / 141

页数：1

相关论文

共 7 条

[1] BORDEN BC, 1996, J CLIN ONCOL, V14, P2627
[2] Dufour P, 1996, ANN ONCOL, V7, P575
[3] Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer
Greco, FA
Figlin, R
York, M
Einhorn, L
Schilsky, R
Marshall, EM
Buys, SS
Froimtchuk, MJ
Schuller, J
Schuchter, L
Buyse, M
Ritter, L
Man, A
Yap, AKL
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2674 - 2681
[4] FLUOROURACIL AND RECOMBINANT ALFA-2A-INTERFERON - AN ACTIVE REGIMEN AGAINST ADVANCED COLORECTAL-CARCINOMA
WADLER, S
SCHWARTZ, EL
GOLDMAN, M
LYVER, A
RADER, M
ZIMMERMAN, M
ITRI, L
WEINBERG, V
WIERNIK, PH
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) : 1769 - 1775
[5] WADLER S, 1992, SEMIN ONCOL, V19, P38
[6] WADLER S, 1990, SEMIN ONCOL, V17, P16
[7] PHASE-II TRIAL OF FLUOROURACIL AND RECOMBINANT INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
WADLER, S
LEMBERSKY, B
ATKINS, M
KIRKWOOD, J
PETRELLI, N
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (10) : 1806 - 1810